Hosted on MSN18d
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancer
The company holds several patents for the composition and use of BCG combined with Anktiva in bladder cancer treatment. The rBCG vaccine, originally developed as a live vaccine against ...
CURE8d
First Patient Dosed With Recombinant Bacillus Calmette-Guérin in Bladder Cancer
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
Physician's Weekly1d
Predictors of Side Effects in Intravesical BCG Therapy for Bladder Cancer
The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus ...
European Medical Journal10d
Treatment Advances in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...
Phys.org23d
Novel nanomotors could improve bladder cancer immunotherapy
Today, the conventional treatment for non-invasive bladder cancer is immunotherapy with BCG (Bacillus Calmette-Guérin), a weakened bacterium that is introduced into the bladder to stimulate an ...
pharmaphorum4d
FDA clears ImmunityBio’s bladder cancer drug at 2nd attempt
After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for ... combination with the BCG vaccine in non-muscle invasive bladder cancer (NMIBC) patients ...
Morningstar9d
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
In bladder cancer clinical trials in Europe, the recombinant BCG vaccine has demonstrated potent ... potential benefits to patients, potential treatment outcomes for patients, the described ...
Business Wire1mon
FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE ® BCG Shortage
In bladder cancer clinical trials in Europe, the recombinant BCG vaccine has demonstrated potent ... potential benefits to patients, potential treatment outcomes for patients, the described ...
Yahoo Finance1mon
FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE® BCG Shortage
The alternative BCG source has been developed by the Serum Institute of India, the world’s largest manufacturer of vaccines by volume. In bladder cancer clinical trials in Europe, the ...
Morningstar1mon
FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE® BCG Shortage
In bladder cancer clinical trials in Europe, the recombinant BCG vaccine has demonstrated potent ... potential benefits to patients, potential treatment outcomes for patients, the described ...